You are here:

fosamprenavir (Telzir)


Following an abbreviated submission

fosamprenavir (Telzir®) in combination with low dose ritonavir is accepted for use within NHS Scotland for the treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infected adolescents and children of six years and above in combination with other antiretroviral medicinal products.

Fosamprenavir is listed in the British National Formulary for Children for the treatment of HIV infection. The Scottish Medicines Consortium has previously accepted this product for use in this indication in adults.

Drug Details

Drug Name: fosamprenavir (Telzir)
SMC Drug ID: 431/07
Manufacturer: GlaxoSmithKline UK Ltd
Indication: HIV1 in adolescents and children of 6 years and above
BNF Category:
Sub Category: 5.3 Antiviral Drugs
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 7 September 2009

Archived Advice

Non submission 10 December 2007